Intravenous Immunoglobulins (IVIG) are often used to treat patients with impaired antibody production or autoimmune conditions[1]. However, according to this paper[2], it can also inhibit antibody production, inhibit B-cell differentiation, inhibit the complement system, and decrease cytokine levels. Is there an increased risk of getting infections while on IVIG treatment given its immunosupressive effects?


  1. https://www.uptodate.com/contents/intravenous-immune-globulin-ivig-beyond-the-basics#H4205572424
  2. Jacob S, Rajabally YA. Current proposed mechanisms of action of intravenous immunoglobulins in inflammatory neuropathies. Curr Neuropharmacol. 2009;7(4):337-342. doi:10.2174/157015909790031166


Your Answer

By clicking “Post Your Answer”, you agree to our terms of service, privacy policy and cookie policy

Browse other questions tagged or ask your own question.